MedPath

Role of ChatGPT in Vestibular Schwannoma Management

Not Applicable
Not yet recruiting
Conditions
Vestibular Schwannoma
Interventions
Behavioral: Use of chatGPT for 1 week
Registration Number
NCT06163664
Lead Sponsor
University of Southern California
Brief Summary

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 18 years or older
  • Diagnosed with vestibular schwannoma
  • Have access to internet-enabled device that is compatible with ChatGPT
Exclusion Criteria
  • < 18 years old
  • patient without diagnosis of vestibular schwannoma
  • patient does not have access to internet-enabled device
  • patient who declines study participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Delayed controlUse of chatGPT for 1 weekNo ChatGPT use for 1 week and intervention after 1 week
InterventionUse of chatGPT for 1 weekIntervention with 1 week use of ChatGPT
Primary Outcome Measures
NameTimeMethod
Changes in scores of Decisional Conflict Scale after ChatGPT usebaseline, 1 week follow up, 2 week follow up

The Decisional Conflict Scale (DCS) measures 5 dimensions of decision making (feeling: uncertain, uninformed, unclear about values, unsupported; ineffective decision making). 15-item validated questionnaire. Score range 5-75 (higher score corresponding to higher levels of conflict in decision making)

Changes in scores of Satisfaction with Decision after ChatGPT usebaseline, 1 week follow up, 2 week follow up

The Satisfaction with Decision (SWD) scale measures satisfaction with health care decisions. 6-item validated questionnaire. Score range 5-30 (higher score corresponding to higher levels of satisfaction with decision)

Changes in scores for Knowledge on vestibular schwannoma management after ChatGPT usebaseline, 1 week follow up, 2 week follow up

4-item questionnaire (Likert scale) assessing participants' confidence in understanding the diagnosis and treatment options for vestibular schwannoma. Score range 5-20 (higher score corresponding to higher levels of confidence in understanding diagnosis and management of vestibular schwannoma)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath